BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BioLife Solutions's book value per share for the quarter that ended in Dec. 2023 was $7.48.
During the past 12 months, BioLife Solutions's average Book Value Per Share Growth Rate was -12.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 58.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BioLife Solutions was 394.20% per year. The lowest was -71.10% per year. And the median was -10.45% per year.
BioLife Solutions's current price is $17.53. Its book value per share for the quarter that ended in Dec. 2023 was $7.48. Hence, today's PB Ratio of BioLife Solutions is 2.34.
During the past 13 years, the highest P/B Ratio of BioLife Solutions was 24.75. The lowest was 1.08. And the median was 3.42.
The historical data trend for BioLife Solutions's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Book Value per Share | Get a 7-Day Free Trial | 2.09 | 6.21 | 11.43 | 8.50 | 7.48 |
BioLife Solutions Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Book Value per Share | Get a 7-Day Free Trial | 8.50 | 8.27 | 8.11 | 7.58 | 7.48 |
For the Medical Instruments & Supplies subindustry, BioLife Solutions's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's PB Ratio distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's PB Ratio falls into.
BioLife Solutions's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (337.7 | - | 0.0) | / | 45.2 | |
= | 7.48 |
BioLife Solutions's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (337.7 | - | 0.0) | / | 45.2 | |
= | 7.48 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
BioLife Solutions (NAS:BLFS) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Thank you for viewing the detailed overview of BioLife Solutions's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Geraint Phillips | officer: SVP, Global Operations | 3303 MONTE VILLA, #310, BOTHELL WA 98021 |
Sarah Aebersold | officer: VP, Global Human Resources | BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Troy Wichterman | officer: Chief Financial Officer | 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Greef Roderick De | director | |
Aby J. Mathew | officer: Chief Tech. Officer & Sr. VP | 3303 MONTE VILLA PARKWAY, #310, BOTHELL WA 98021 |
Todd Berard | officer: Vice President, Marketing | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Karen A. Foster | officer: Vice President of Operations | C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Michael Rice | director, officer: President & CEO | C/O BIOLIFE SOLUTIONS, INC., 171 FRONT STREET, OWEGO NY 13827 |
Casdin Partners Master Fund, L.p. | 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Garrie Richardson | officer: Chief Revenue Officer | 3303 MONTE VILA PARKWAY, BOTHELL WA 98021 |
Marcus Schulz | officer: Vice President, Global Sales | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Joseph C Schick | director | 16719 NE 139TH PLACE, WOODINVILLE WA 98072 |
Amy Duross | director | 8410 GOLDEN BEAR PLACE, WHISTLER A1 V8E 1J7 |
Timothy L. Moore | director | C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404 |
Joydeep Goswami | director | SUMITOMO FUDOSAN MITA TWIN BLDG, EAST WING 4-2-8 SHIBAURA MINATO-KU, TOKYO M0 1080023 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 12-01-2022
By PRNewswire • 11-02-2023
By PRNewswire PRNewswire • 06-06-2023
By PRNewswire • 10-19-2023
By GuruFocus Research GuruFocus Editor • 12-31-2022
By PRNewswire PRNewswire • 06-19-2022
By PRNewswire PRNewswire • 06-14-2023
By PRNewswire PRNewswire • 05-02-2023
By PRNewswire PRNewswire • 01-09-2023
By GuruFocus Research GuruFocus Editor • 05-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.